R. Kurman

Reproductive Medicine · 2002–2017

A researcher in the Science corpus: 13 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

• Reproductive Medicine — 40 citations into it; #54 of 208 by trust here, #11 by citations
• Oncology — 29 citations into it; #1,329 of 1,698 by trust here, #1,046 by citations
• Genetics — 22 citations into it
• Obstetrics and Gynecology — 19 citations into it; #22 of 81 by trust here, #5 by citations
• Cancer Research — 14 citations into it; #1,166 of 1,780 by trust here, #1,105 by citations

Whom R. Kurman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Ie-Ming Shih
2. V. Beral
3. T. Kuhn

Who trusts R. Kurman overall

1. Ie-Ming Shih
2. E. Lengyel
3. J. Prat
4. Hodgkin Lymphoma

Papers from R. Kurman's perspective

Ordered by how strongly the researchers R. Kurman trusts endorse each paper. Same corpus, a different order for every researcher.

1. The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome (American Journal of Surgical Pathology)
2. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer (Journal of Pathology)
3. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status (Nature)
4. PD-1 blockade in tumors with mismatch repair deficiency. (Journal of Clinical Oncology)
5. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. (The Lancet)
6. A candidate precursor to serous carcinoma that originates in the distal fallopian tube
7. Mutation of the PIK3CA Gene in Ovarian and Breast Cancer (Cancer Research)
8. Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma (Science)
9. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. (American Journal of Human Genetics)
10. ARID1A mutations in endometriosis-associated ovarian carcinomas. (New England Journal of Medicine)

Their papers

• High grade serous ovarian carcinomas originate in the fallopian tube (2017) — 662 citations
• The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. (2016) — 895 citations
• WHO classification of tumours of female reproductive organs (2014) — 1,929 citations
• Molecular Pathogenesis and Extraovarian Origin of Epithelial Ovarian Cancer. Shifting the Paradigm (2011) — 1,080 citations
• The Origin and Pathogenesis of Epithelial Ovarian Cancer- a Proposed Unifying Theory (2010) — 1,864 citations
• Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. (2010) — 638 citations
• A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. (2009) — 895 citations
• OVARIAN LOW-GRADE AND HIGH-GRADE SEROUS CARCINOMA: Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems (2009) — 608 citations
• Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (2007) — 1,759 citations
• Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. (2005) — 1,716 citations
• Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. (2004) — 1,291 citations
• Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. (2003) — 899 citations
• The 2001 Bethesda System: terminology for reporting results of cervical cytology. (2002) — 3,434 citations